Biotech Stocks: Amgen Rallies to New Highs

  • ADMIN
  • 4 Months ago
  • 0
The biotech industry is one of the most closely watched sectors in the stock market, and the first quarter of 2017 has been no exception to this rule.  All of the media discussion about President Trump’s repeal and replacement of Obamacare led many to believe the healthcare sector would see a major sell-off.  But when […]

Stock Trading: Gilead Sciences Ready to Reverse?

  • ADMIN
  • 5 Months ago
  • 0
Gilead Sciences, Inc. (NASDAQ: GILD) is a research-based biopharmaceutical company and one of the largest biotech entities in the world.  The company promotes a principal focus that includes the human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and […]

Financial Markets: Looking At Biotech Stocks in 2017

  • ADMIN
  • 6 Months ago
  • 0
In 2016, we saw some significant trends develop in the financial markets.  Most of the early optimism was centered in areas like precious metals, where assets like gold and silver were seeing multi-year rallies.  But these trends have clearly turned, with investors now more heavily focused on stocks — and several benchmarks have now risen […]